#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Francesco Sirci Email
Deputy Head Discovery . STALICLA
Genève,
LocationPrimary Email
How to contact Francesco Sirci
Join and see Francesco's contact info for free!Current Roles
Employees:
29Revenue:
$4.5MAbout
STALICLA is a near clinical Company developing a first in class precision medicine platform to accelerate drug development for patients with Neurodevelopmental Disorders (NDDs). First focus of development has been Autism Spectrum Disorder (ASD). Today, patients diagnosed with ASD account for 1-1.5% of the world population. The condition remains a high unmet medical need. In its Geneva and Barcelona units, STALICLA has assembled a world class team of experienced drug developers and computational biologists. The company is recognized as a disruptive player, using its DEPIv3 innovative systems biology AI platform. DEPIv3 integrates domain specific large-scale genetic, molecular, pharmacological and clinical data to define patient subgroups and to identify personalized treatments. It is the first time that such technologies have been utilized within the field of neurodevelopment with the potential to change the direction of the specialty. In just over 2.5 years, the STALICLA platform has already proven successful in expediting and de-risking drug development for a first subgroup of patients with Autism and identifying two additional subgroups. STALICLA's first therapeutic package - STP1 - addresses this first distinct subgroup of ASD patients estimated to 1.5 - 2M people in the EU and North America. Clinical entry for STP1 is planned in Q1 2020. To support its platform and pipeline development, STALICLA has developed a network of top tier research and clinical partners in the US. This has enabled STALICLA to gather one of the largest Autism patients Electronic Health Records database to date. STALICLA is currently scaling up DEPIv3 to advance new pipelines for additional groups of patients with NDDs.STALICLA Address
Av. de Sécheron 15Genève, null